Niels Plath
H Lundbeck A/SCopenhagen, Denmark
330978 RESULTS
H Lundbeck A/SCopenhagen, Denmark
University of QueenslandHerston, Australia
PAPER Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK,
RESEARCH NEWS 2005-11-11 Research News A high failure rate of new therapeutics during the clinical development process makes drug development a risky business. Many promising drug candidates crash and burn when they elicit unpredicted and unacceptable side effects. What if it wer
PAPER Hagens O, Minina E, Schweiger S, Ropers HH, Kalscheuer V
PAPER Blais V, Turrin NP, Rivest S
PAPER Liu F, Gong X, Zhang G, Marquis K, Reinhart P, Andree TH
PAPER de Chiara C, Menon RP, Dal Piaz F, Calder L, Pastore A
PAPER Hartley M, Taylor N, Taylor J
PAPER Gisabella B, Bolshakov VY, Benes FM
PAPER Iwata A, Christianson JC, Bucci M, Ellerby LM, Nukina N, Forno LS, Kopito RR
PAPER Buerger K, Ewers M, Andreasen N, Zinkowski R, Ishiguro K, Vanmechelen E, Teipel SJ, Graz C, Blennow K, Hampel H
PAPER Ogunniyi A, Hall KS, Baiyewu O, Gureje O, Unverzagt FW, Gao S, Hendrie HC
PAPER Joo SS, Lee DI
PAPER Wang W, Rusin O, Xu X, Kim KK, Escobedo JO, Fakayode SO, Fletcher KA, Lowry M, Schowalter CM, Lawrence CM, Fronczek FR, Warner IM, Strongin RM